Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion

Cancer Research

Volumn 68, Issue 5, 2008, Pages 1254-1260

  Schmid, Tobias ^a   Jansen, Aaron P ^a   Baker, Alyson R ^a   Hegamyer, Glenn ^a   Hagan, John P ^a,b   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GLYCOGEN SYNTHASE KINASE 3BETA; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEASOME; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN PDCD4; S6 KINASE; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SKIN PAPILLOMA; TUMOR GROWTH; UBIQUITINATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, TRANSGENIC; PROTEASOME ENDOPEPTIDASE COMPLEX; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 40449091284     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1719     Document Type: Article

References (22)